Cited 45 times in
Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.